Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis

INTRODUCTION: The safety and efficacy of recombinant human soluble thrombomodulin (rhTM) have been demonstrated, with promising evidence suggestive of efficacy for patients with severe sepsis involving coagulopathy in a phase IIb randomized controlled trial. However, the benefit profiles of rhTM hav...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Crit Care
Κύριοι συγγραφείς: Yoshimura, Jumpei, Yamakawa, Kazuma, Ogura, Hiroshi, Umemura, Yutaka, Takahashi, Hiroki, Morikawa, Miki, Inoue, Yoshiaki, Fujimi, Satoshi, Tanaka, Hiroshi, Hamasaki, Toshimitsu, Shimazu, Takeshi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2015
Θέματα:
Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367899/
https://ncbi.nlm.nih.gov/pubmed/25883031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0810-3
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια